When patients are prescribed complex therapies — like specialty drugs, cell and gene treatments, or high-cost biologics — the path to treatment is rarely straightforward. Filling a prescription can ...
In 2024, the pharma industry found itself with a growing “trust paradox.” While innovations like gene therapies and rare disease treatments were being celebrated, skepticism surrounding accessibility, ...
BERLIN--(BUSINESS WIRE)--Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by ...
China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) (“China SXT” or the “Company”), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of ...
POTOMAC, MARYLAND / ACCESS Newswire / April 24, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "Company") today announced that the Company's recently appointed advisors entered into a Share ...
A planning committee of the National Academies of Sciences, Engineering, and Medicine will host a workshop exploring strategic "make, buy, and invest" actions to bolster the resilience of the U.S.
Pharma Equity Group A/S (“PEG” or the “Company”) hereby provides a strategic update regarding the Company’s revenue expectations, the development of the pipeline projects RNX-051 and RNX-011, and the ...
Aseptic processing demands reliable, robust, and validated analytical methods to ensure sterility, safety, and quality, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback